Document Detail


Cardioprotection afforded by St Thomas solution is enhanced by emulsified isoflurane in an isolated heart ischemia reperfusion injury model in rats.
MedLine Citation:
PMID:  20123239     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this study was to investigate whether adding emulsified isoflurane to St Thomas cardioplegia solution could enhance the cardiac protection after cardioplegic arrest in rats. DESIGN: A randomized, blind study. SETTING: A university laboratory. PARTICIPANTS: Thirty male Sprague-Dawley rats. INTERVENTIONS: Thirty isolated heart preparations were randomly divided into 3 groups (n = 10/group) according to the different cardioplegia solutions being given: St Thomas solution mixed with emulsified isoflurane (containing 2.8% of isoflurane, group EI), St Thomas solution mixed with emulsified Intralipid (Huarui Pharmacy, Wuxi, Jiangsu, China) (group EL), and St Thomas solution alone (group St). In the 35-minute normothermic ischemia period, infusion of cardioplegia solution was repeated every 15 minutes. After the 35-minute ischemia period, the heart was perfused with Krebs-Henseleit buffer for another 2 hours. MEASUREMENTS AND MAIN RESULTS: The functional parameters of the heart were monitored throughout the experiments. The coronary effluent was collected for measuring the activity of CK-MB 30 minutes after reperfusion, and the infarct size was assessed at the end of reperfusion. The infarct size in group EI (24% +/- 4%) was reduced when compared with that in group EL (31% +/- 8%, p < 0.05) and group St (43% +/- 9%, p < 0.001). The CK-MB activity in group EI was decreased significantly when compared with that in group EL and group St (p < 0.05). The functional recovery in group EI also was improved. Compared with standard St Thomas solution alone, adding 30% Intralipid alone also significantly reduced the infarct size and the CK-MB leakage and improved the recovery of the mechanical function. CONCLUSIONS: St Thomas cardioplegia solution supplemented with emulsified isoflurane enhanced its cardioprotection in an isolated heart ischemia reperfusion injury model in rats.
Authors:
Han Huang; Wensheng Zhang; Shanling Liu; Chen Yanfang; Tao Li; Jin Liu
Related Documents :
1952129 - Effects of cardiopulmonary bypass and cardioplegia on regional and global cardiac actio...
6179199 - Prolonged safe ischemic cardiac arrest using hypothermic bretschneider cardioplegia com...
6608419 - A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 6...
21728209 - Prenatal diagnosis of fetal left ventricular non-compaction cardiomyopathy.
8355399 - Evaluation of the effectiveness of 5'-nucleotidase inhibitor and allopurinol in myocard...
22512699 - Diagnostic performance of p wave duration in the identification of left atrial enlargem...
8941119 - 17 beta-estradiol prevents dysfunction of canine coronary endothelium and myocardium an...
2335409 - Electrocardiographic abnormalities and left ventricular systolic function in chagas' he...
17510289 - Facets of openness predict mortality in patients with cardiac disease.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiothoracic and vascular anesthesia     Volume:  24     ISSN:  1532-8422     ISO Abbreviation:  J. Cardiothorac. Vasc. Anesth.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-03     Completed Date:  2010-05-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9110208     Medline TA:  J Cardiothorac Vasc Anesth     Country:  United States    
Other Details:
Languages:  eng     Pagination:  99-103     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Anesthesiology, West China Second Hospital, Sichuan University, Chengdu, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthetics, Inhalation / pharmacology*
Animals
Bicarbonates / chemistry,  pharmacology
Calcium Chloride / chemistry,  pharmacology
Cardioplegic Solutions / pharmacology*
Creatine Kinase, MB Form / analysis
Disease Models, Animal
Fat Emulsions, Intravenous / pharmacology
Heart / drug effects*
Hemodynamics / drug effects
Isoflurane / pharmacology*
Magnesium / chemistry,  pharmacology
Male
Myocardial Infarction / pathology,  prevention & control
Potassium Chloride / chemistry,  pharmacology
Random Allocation
Rats
Rats, Sprague-Dawley
Reperfusion Injury / drug therapy*
Sodium Chloride / chemistry,  pharmacology
Therapeutics
Chemical
Reg. No./Substance:
0/Anesthetics, Inhalation; 0/Bicarbonates; 0/Cardioplegic Solutions; 0/Fat Emulsions, Intravenous; 0/St. Thomas' Hospital cardioplegic solution; 10043-52-4/Calcium Chloride; 26675-46-7/Isoflurane; 7439-95-4/Magnesium; 7447-40-7/Potassium Chloride; 7647-14-5/Sodium Chloride; EC 2.7.3.2/Creatine Kinase, MB Form

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preoperative Heparin Therapy Causes Immune-Mediated Hypotension Upon Heparin Administration for Card...
Next Document:  A novel non-invasive method to assess aortic valve opening in HeartMate II left ventricular assist d...